Titre : Réaction transfusionnelle

Réaction transfusionnelle : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Réaction transfusionnelle : Questions médicales les plus fréquentes", "headline": "Réaction transfusionnelle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Réaction transfusionnelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-21", "dateModified": "2025-04-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Réaction transfusionnelle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies du système immunitaire", "url": "https://questionsmedicales.fr/mesh/D007154", "about": { "@type": "MedicalCondition", "name": "Maladies du système immunitaire", "code": { "@type": "MedicalCode", "code": "D007154", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Oedème pulmonaire lésionnel aigu post-transfusionnel", "alternateName": "Transfusion-Related Acute Lung Injury", "url": "https://questionsmedicales.fr/mesh/D000073617", "about": { "@type": "MedicalCondition", "name": "Oedème pulmonaire lésionnel aigu post-transfusionnel", "code": { "@type": "MedicalCode", "code": "D000073617", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.920.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Réaction transfusionnelle", "alternateName": "Transfusion Reaction", "code": { "@type": "MedicalCode", "code": "D065227", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "Department of Vigilance, Haemovigilance, établissement français du sang Auvergne Rhône-Alpes, site de Lyon Décines, 111, rue Elisée-Reclus CS 20617, 69153 Décines-Charpieu cedex, France." } }, { "@type": "Person", "name": "Ryu Yanagisawa", "url": "https://questionsmedicales.fr/author/Ryu%20Yanagisawa", "affiliation": { "@type": "Organization", "name": "Division of Blood Transfusion, Shinshu University Hospital, Matsumoto, Japan." } }, { "@type": "Person", "name": "Jeanne E Hendrickson", "url": "https://questionsmedicales.fr/author/Jeanne%20E%20Hendrickson", "affiliation": { "@type": "Organization", "name": "Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT." } }, { "@type": "Person", "name": "P Moncharmont", "url": "https://questionsmedicales.fr/author/P%20Moncharmont", "affiliation": { "@type": "Organization", "name": "Département des vigilances, hémovigilance, établissement français du sang Auvergne Rhône-Alpes, site de Lyon-Décines, 111, rue Élisée-Reclus, CS 20617, 69153 Décines-Charpieu cedex, France. Electronic address: pierre.moncharmont@efs.sante.fr." } }, { "@type": "Person", "name": "Jun Kobayashi", "url": "https://questionsmedicales.fr/author/Jun%20Kobayashi", "affiliation": { "@type": "Organization", "name": "Department of Laboratory Medicine, Nagano Children's Hospital, Azumino, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Plasma exchange in acute hemolytic reaction due to ABO-incompatible erythrocyte concentrate transfusions: Single center experience.", "datePublished": "2023-06-28", "url": "https://questionsmedicales.fr/article/37379860", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/tme.12982" } }, { "@type": "ScholarlyArticle", "name": "Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components - A scoping review.", "datePublished": "2022-07-14", "url": "https://questionsmedicales.fr/article/35871104", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.blre.2022.100989" } }, { "@type": "ScholarlyArticle", "name": "Basophil activation test for allergic and febrile non-haemolytic transfusion reactions among paediatric patients with haematological or oncological disease.", "datePublished": "2022-10-12", "url": "https://questionsmedicales.fr/article/36224113", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/vox.13365" } }, { "@type": "ScholarlyArticle", "name": "Delayed haemolytic transfusion reaction in paediatric patients with sickle cell disease: A retrospective study in a French national reference centre.", "datePublished": "2022-12-21", "url": "https://questionsmedicales.fr/article/36541848", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/bjh.18605" } }, { "@type": "ScholarlyArticle", "name": "Major histocompatibility complex (MHC) antigens polymorphism and alloimmunization study in thalassemia patients with febrile non-hemolytic transfusion reaction (FNHTR).", "datePublished": "2022-10-31", "url": "https://questionsmedicales.fr/article/36328308", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.tracli.2022.10.008" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Réaction transfusionnelle", "item": "https://questionsmedicales.fr/mesh/D065227" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Réaction transfusionnelle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Réaction transfusionnelle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Réaction transfusionnelle", "description": "Comment diagnostiquer une réaction transfusionnelle ?\nQuels tests sont utilisés pour confirmer une réaction ?\nQuels signes cliniques indiquent une réaction ?\nQuand doit-on suspecter une réaction transfusionnelle ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D065227?page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Réaction transfusionnelle", "description": "Quels sont les symptômes courants d'une réaction transfusionnelle ?\nLes réactions transfusionnelles provoquent-elles des douleurs ?\nPeut-on avoir des symptômes respiratoires ?\nLes éruptions cutanées sont-elles fréquentes ?\nComment différencier une réaction allergique d'une transfusion ?", "url": "https://questionsmedicales.fr/mesh/D065227?page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Réaction transfusionnelle", "description": "Comment prévenir les réactions transfusionnelles ?\nQuel rôle joue le consentement éclairé ?\nLes tests de compatibilité sont-ils obligatoires ?\nComment former le personnel médical à la prévention ?\nLes banques de sang effectuent-elles des tests préventifs ?", "url": "https://questionsmedicales.fr/mesh/D065227?page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Réaction transfusionnelle", "description": "Quel est le traitement immédiat d'une réaction transfusionnelle ?\nFaut-il surveiller le patient après une réaction ?\nLes fluides intraveineux sont-ils nécessaires ?\nQuand utiliser des médicaments immunosuppresseurs ?\nLes transfusions futures nécessitent-elles des précautions ?", "url": "https://questionsmedicales.fr/mesh/D065227?page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Réaction transfusionnelle", "description": "Quelles sont les complications possibles d'une réaction transfusionnelle ?\nComment l'insuffisance rénale se manifeste-t-elle ?\nLe choc peut-il être fatal ?\nLes infections sont-elles une préoccupation après une transfusion ?\nComment gérer les complications post-transfusionnelles ?", "url": "https://questionsmedicales.fr/mesh/D065227?page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Réaction transfusionnelle", "description": "Quels sont les facteurs de risque de réactions transfusionnelles ?\nLes patients âgés sont-ils plus à risque ?\nLes femmes enceintes sont-elles plus susceptibles ?\nLes patients ayant des maladies auto-immunes sont-ils à risque ?\nLes transfusions multiples augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D065227?page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une réaction transfusionnelle ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'observation des symptômes et des tests sanguins." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer une réaction ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de compatibilité et des analyses de sang sont effectués." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une réaction ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, éruptions cutanées et douleurs lombaires sont des signes courants." } }, { "@type": "Question", "name": "Quand doit-on suspecter une réaction transfusionnelle ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Si des symptômes apparaissent dans les heures suivant la transfusion." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique aide à identifier des sensibilisations antérieures aux antigènes." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une réaction transfusionnelle ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, éruptions cutanées, douleurs thoraciques et hypotension." } }, { "@type": "Question", "name": "Les réactions transfusionnelles provoquent-elles des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs lombaires ou thoraciques peuvent survenir." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes respiratoires ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des difficultés respiratoires peuvent se manifester dans certains cas." } }, { "@type": "Question", "name": "Les éruptions cutanées sont-elles fréquentes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des éruptions cutanées peuvent apparaître après une transfusion." } }, { "@type": "Question", "name": "Comment différencier une réaction allergique d'une transfusion ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les réactions allergiques sont souvent localisées, tandis que les transfusionnelles sont systémiques." } }, { "@type": "Question", "name": "Comment prévenir les réactions transfusionnelles ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Assurer une compatibilité sanguine rigoureuse et un suivi des antécédents du patient." } }, { "@type": "Question", "name": "Quel rôle joue le consentement éclairé ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le consentement éclairé informe le patient des risques associés aux transfusions." } }, { "@type": "Question", "name": "Les tests de compatibilité sont-ils obligatoires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont essentiels pour minimiser le risque de réactions transfusionnelles." } }, { "@type": "Question", "name": "Comment former le personnel médical à la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des formations régulières sur les protocoles transfusionnels sont nécessaires." } }, { "@type": "Question", "name": "Les banques de sang effectuent-elles des tests préventifs ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles réalisent des tests pour détecter des anticorps et des infections." } }, { "@type": "Question", "name": "Quel est le traitement immédiat d'une réaction transfusionnelle ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Arrêter la transfusion et administrer des antihistaminiques ou des corticostéroïdes." } }, { "@type": "Question", "name": "Faut-il surveiller le patient après une réaction ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une surveillance étroite est nécessaire pour détecter d'éventuelles complications." } }, { "@type": "Question", "name": "Les fluides intraveineux sont-ils nécessaires ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des fluides peuvent être administrés pour maintenir la pression artérielle." } }, { "@type": "Question", "name": "Quand utiliser des médicaments immunosuppresseurs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "En cas de réactions sévères, des immunosuppresseurs peuvent être envisagés." } }, { "@type": "Question", "name": "Les transfusions futures nécessitent-elles des précautions ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests supplémentaires et une surveillance accrue sont recommandés." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une réaction transfusionnelle ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance rénale, le choc et les infections." } }, { "@type": "Question", "name": "Comment l'insuffisance rénale se manifeste-t-elle ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par une diminution de la production d'urine et un œdème." } }, { "@type": "Question", "name": "Le choc peut-il être fatal ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le choc anaphylactique ou septique peut être mortel sans traitement rapide." } }, { "@type": "Question", "name": "Les infections sont-elles une préoccupation après une transfusion ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections virales ou bactériennes peuvent survenir après une transfusion." } }, { "@type": "Question", "name": "Comment gérer les complications post-transfusionnelles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une prise en charge rapide et appropriée est cruciale pour limiter les séquelles." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de réactions transfusionnelles ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Antécédents de transfusions, immunodépression et incompatibilité sanguine augmentent le risque." } }, { "@type": "Question", "name": "Les patients âgés sont-ils plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients âgés peuvent avoir un risque accru de complications transfusionnelles." } }, { "@type": "Question", "name": "Les femmes enceintes sont-elles plus susceptibles ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent développer des anticorps anti-Rh, augmentant le risque lors de transfusions." } }, { "@type": "Question", "name": "Les patients ayant des maladies auto-immunes sont-ils à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent avoir une réponse immunitaire exacerbée aux transfusions." } }, { "@type": "Question", "name": "Les transfusions multiples augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les transfusions répétées augmentent le risque de sensibilisation et de réactions." } } ] } ] }

Sources (10000 au total)

Plasma exchange in acute hemolytic reaction due to ABO-incompatible erythrocyte concentrate transfusions: Single center experience.

Acute hemolytic transfusion reaction (AHTR) due to ABO-incompatible erythrocyte concentrate (EC) is one of the most catastrophic complications of transfusion. Since the hemolysis is intravascular; hem... Treatment of AHTR is mostly supportive measures. Today there are no clear suggestions about plasma exchange (PE) in these patients.... Here we report our experience with six patients diagnosed with AHTR due to ABO-incompatible EC transfusion.... We performed PE in 5 of these patients. Although all of our patients were geriatric and most of them had significant comorbidities four out of five patients recovered without an incident.... Although PE is considered a last-chance treatment when other measures fail in the literature, our experience above indicates that it must be evaluated in every patient with AHTR early in the course. I...

Basophil activation test for allergic and febrile non-haemolytic transfusion reactions among paediatric patients with haematological or oncological disease.

Allergic transfusion reactions (ATRs) and febrile non-haemolytic transfusion reactions (FNHTRs) are common, although their mechanisms remain unclear. Immunoglobulin E (IgE)-mediated type I hypersensit... The BAT was based on peripheral blood samples from paediatric patients with a haematological or oncological disease and on samples of residual blood products transfused in each case. Dasatinib was use... Twenty-seven patients with and 19 patients without ATR/FNHTR were included in this study, respectively. The median BAT values associated with ATR- (n = 41) and FNHTR-causing (n = 5) blood products wer... The IgE-mediated type I hypersensitivity may be involved in the pathogenesis of ATR and FNHTR. BAT analyses may help elucidate the underlying mechanisms and identify patients at risk....

Major histocompatibility complex (MHC) antigens polymorphism and alloimmunization study in thalassemia patients with febrile non-hemolytic transfusion reaction (FNHTR).

HLA alloimmunization is one of the most troublesome consequence of regular transfusion which is itself a mainstay measure to provide longevity to the thalassemia patients. Febrile non-hemolytic transf... Total of 60 β-thalassemia patients with FNHTR (case group) and 20 β-thalassemia patients without FNHTR (control group) randomly have been selected and enrolled in the study. All were tested for HLA-A ... Totally, a significant predominance was noted for two HLA alleles, HLA-A*24 (P = 0.029) and B*55 (P = 0.034) which have higher prevalence in control group. Although no significant association was foun... Here some evidences about the possible role of HLA polymorphism in susceptibility to FNHTR are provided. Those results indicated that HLA-A*24 and HLA-B*55 might play protective role on inducing FNHTR...

Should adding pain, oxygen saturation and physical assessment to vital signs become the new standard of care for detecting blood transfusion reactions?

Clinicians sought to ascertain what frequency of vital signs best detects blood transfusion reactions. This review discusses early and delayed blood product transfusion reaction detection through the ... A comprehensive appraisal of published literature was conducted using Integrative Research Review methodology through June 2022 not limited to English or research in Cumulative Index to Nursing and Al... Full-text articles in the final sample included four articles discussing vital signs detecting blood transfusion reactions and four articles reporting the importance of adding physical assessments for... Vital sign components varied across reviewed studies. Respiratory rate and pain were not always included in 'vital signs' to identify transfusion reactions. Only low-level data and no clinical trials ...

Solvent/detergent treated pooled human plasma can decrease the recurrence of allergic transfusion reactions in pediatric, adolescent, and young adult patients.

Octaplas is a solvent/detergent (S/D)-treated pooled human plasma indicated for the treatment of thrombotic thrombocytopenic purpura (TTP) as well as multiple coagulation factor deficiency in patients... A single-center retrospective review of patient records was performed from January 2018 through July 2022 for patients who received S/D treated plasma (Octaplas™; Octapharma).... A total of 1415 units of S/D-treated plasma were transfused to nine patients at our institution. Patient ages ranged from 13 months to 25 years old. The reason to initiate transfusion with S/D treated... We have successfully utilized S/D treated plasma over the last 4.5 years for pediatric, adolescent, and young adult patients who otherwise would have suffered ATR due to necessary TPE or PT. S/D treat...

Pre-transfusion Testing Using Crossmatching Agglutination Reaction Grades Combined With Rh Subgroup Phenotyping in Patients With Autoantibodies: A Three-year Experience at a Tertiary Hospital.

The currently recommended pre-transfusion testing techniques for patients with autoantibodies are complex, time-consuming, and labor-intensive. Therefore, although the red blood cell (RBC) selection m... We retrospectively investigated RBC transfusions from January 2019 to December 2021 in patients presenting as auto-control-positive via antibody identification (auto-control (+) group), where Rh subgr... In the auto-control (+) group, the Hb change per unit among different agglutination reaction grades of transfused RBCs and among different relative grades of transfused RBCs and crossmatching auto-con... Together with Rh subgroup phenotyping, selecting the RBC unit with the lowest agglutination reaction grade upon crossmatching does not adversely affect transfusion efficiency....

A case of mistaken MELD (model for end stage liver disease) score-How an acute hemolytic transfusion reaction falsely altered a patient's transplant status.

An acute hemolytic transfusion reaction (AHTR) caused by intravascular hemolysis features a decrease in hemoglobin/hematocrit, reduced haptoglobin, and increases in creatinine, and bilirubin. Acute in... Herein, we present a case of a patient with hepatorenal syndrome due to ESLD on the transplant list who developed an AHTR due to an evolving anti-Jka that initially presented as non-specific reactivit... Acute hemolysis caused significant elevation of bilirubin raising the MELD score which increased both the predicted mortality to 70 percent and the perceived urgency of transplant. The MELD score impr... This case highlights the effect of AHTR on parameters used in the determination of MELD score which significantly increases the perceived short-term mortality and urgency of liver transplant. Therefor...

Transfusion-related acute lung injury/transfusion-associated circulatory overload in a child with non-transfusion dependent thalassemia and aplastic crisis due to acute parvovirus B19 infection.

We present a never-transfused girl with thalassemia intermedia who was admitted for febrile aplastic crisis due to human parvovirus B19. After a first transfusion of packed red blood cells, she develo...